# Daptomycin or Vancomycin Plus Ceftaroline for Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections

## Authors

- Guang-Mao Lee ([ORCID](https://orcid.org/0000-0003-0235-9060)) — Department of Nursing, Kaohsiung Municipal United Hospital, Taiwan
- Chien-Ming Chao ([ORCID](https://orcid.org/0000-0001-9702-7928)) — Department of Intensive Care Medicine, Chi-Mei Medical Center, Liouying, Taiwan

## Article information

- **Journal:** The Ulutas Medical Journal (Ulutas Med J), ISSN 2149-388X
- **Issue:** Volume 6, Issue 3 (2020), pages 185–187
- **Article type:** Letter to the Editor
- **Published online:** 2020-09-19
- **DOI:** [10.5455/umj.20200513022718](https://doi.org/10.5455/umj.20200513022718)
- **Licence:** [CC BY-NC 4.0](https://creativecommons.org/licenses/by-nc/4.0/)
- **Article page:** https://www.ulutasmedicaljournal.com/?mno=106884
- **PDF:** https://www.ulutasmedicaljournal.com/pdf/106884.pdf

## Abstract

The clinical outcomes of patients with MRSA bacteremia treated with ceftaroline plus vancomycin or daptomycin were similar to those treated with monotherapy with vancomycin or daptomycin. However, this analysis has limited case and study numbers; larger-scale studies are warranted to confirm these findings.

## Keywords

Methicillin-resistant Staphylococcus aureus; Bloodstream Infection

## How to cite

Lee GM, Chao CM. Daptomycin or Vancomycin Plus Ceftaroline for Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections. Ulutas Med J. 2020;6(3):185-187. doi:10.5455/umj.20200513022718

## References

1. Holick MF, Krane SM, Potts JT. Calcium, phosphorus, and bone metabolism: Calcium-regulation hormones. In: Fauci AS, Braunwald E, Isselbacher KJ, et al (Eds). Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill; 1995:2214
2. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc. 2011;86(1):50-60
3. Gal-Moscovici A, Sprague SM: Role of Vitamin D deficiency in chronic kidney Disease. J Bone Miner Res. 2007;22:91-94 https://doi.org/10.1359/jbmr.07s203
4. Michael F. Holick: Vitamin D for Health and in chronic kidney disease.Seminars in Dialysis - vol 18, No 4, 2005 https://doi.org/10.1111/j.1525-139x.2005.18402.x
5. Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res. 2014;7:69-87 https://doi.org/10.2147/jir.s63898
6. Taskapan H, Wei M, Oreopoulos DG. 25(OH) Vitamin D(3) in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol. 2006;38(2): 323-329 https://doi.org/10.1007/s11255-006-0081-7
7. Hossein-nezhad A, Holick MF. Vitamin D for health: A Global perspective. Mayo Clin Proc. 2013;88(7):720–55 https://doi.org/10.1016/j.mayocp.2013.05.011
8. Türkiye Endokrinoloji ve Metabolizma Derneği. Osteoporoz ve Metabolik Kemik Hastalıkları Tanı ve Tedavi Kılavuzu 2018: 119-27
9. Jean G, Souberbielle JC, Chazot C. Vitamin D in chronic kidney disease and dialysis patients. Nutrients. 2017;9(4):1-15 https://doi.org/10.3390/nu9040328
10. Keung L, Perwad F. Vitamin D and kidney disease. Bone Rep. 2018;9:93-100 https://doi.org/10.1016/j.bonr.2018.07.002
11. Eknoyan G, Lameire M, Kasiske B. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59 https://doi.org/10.1016/j.kisu.2017.10.001
12. Eknoyan G,Levin NM: Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:1-201 https://doi.org/10.1016/s0272-6386(03)00905-3
13. Gonzales EA,Sachdeva A,Oliver DA et al. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol. 2004;24: 503-510
14. Tokmak F, Quack I, Schieren G, Sellin L, Rattensperger D, HollandLetz T, Weiner SM, Rump LC: High-dose chole calciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant. 2008;23:4016-4020 https://doi.org/10.1093/ndt/gfn367
15. Tentori F,Stidley C,Brown R et al:Survival does not differ among incident hemodialysis patients treated with the different vitamin D analogs, in vol (F-PO940), American Society of Nephrology Meeting, 2003